GlassScriptPhysician profile
Shervin Eshaghian
NPI 1760695696
$9,563.81
in general payments reported to CMS, 2019-2025
35 companies · $939 in 2025
The $939 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $1,381 · 2021: $1,894 · 2022: $1,482 · 2023: $1,194 · 2024: $1,231 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,364.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,403.64 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $1,273.34 | 2019-2025 | |
| Amgen INC. | $1,258.57 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,061.65 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $850.78 | 2019-2024 | Brilinta, Farxiga |
| Pfizer INC. | $759.07 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $562.53 | 2019-2025 | Eliquis, Opdivo, Opdualag |
| Amarin Pharma, INC. | $400.50 | 2019-2021 | |
| Boston Scientific Corporation | $276.49 | 2019-2024 | Advantage System |
| Bayer Healthcare Pharmaceuticals INC. | $188.45 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $167.24 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.37 | 2019-2024 | Lifevest |
| Baxter Healthcare | $132.65 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $117.44 | 2020-2022 | |
| Abbott Laboratories | $95.06 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $85.98 | 2021-2023 | Arcalyst |
| Bridgebio Pharma, INC. | $79.96 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $77.82 | 2023-2024 | Inpefa |
| Bardy Diagnostics, INC. | $73.86 | 2019-2021 | |
| Scpharmaceuticals INC. | $58.97 | 2023-2025 | |
| Novo Nordisk INC | $57.91 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $57.86 | 2021 | |
| Heartflow, INC. | $42.94 | 2025 | |
| Sanofi-Aventis U.S. LLC | $40.46 | 2019 | |
| Biotronik INC. | $40.22 | 2021 | |
| Esperion Therapeutics, INC. | $37.56 | 2021-2024 | Nexletol |
| Irhythm Technologies, INC. | $26.59 | 2023 | Zio Xt Patch |
| Csl Behring | $26.49 | 2020 | |
| Eisai INC. | $25.75 | 2020 | |
| Preventice Services, LLC | $22.74 | 2021 | |
| Abbvie INC. | $22.31 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.47 | 2019 | |
| Adc Therapeutics America, INC. | $20.19 | 2022 | |
| Lilly USA, LLC | $18.07 | 2020 | |
| Daiichi Sankyo INC. | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shervin Eshaghian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.